175 related articles for article (PubMed ID: 2858801)
1. Binding of a novel dopaminergic agonist radioligand [3H]-fenoldopam (SKF 82526) to D-1 receptors in rat striatum.
Flaim KE; Gessner GW; Crooke ST; Sarau HM; Weinstock J
Life Sci; 1985 Apr; 36(15):1427-36. PubMed ID: 2858801
[TBL] [Abstract][Full Text] [Related]
2. Regulation of agonist and antagonist binding to striatal D-1 dopamine receptors: studies using the selective D-1 antagonist [3H]SK&F R-83566.
Flaim KE; Gessner GW; Crooke ST; Heys JR; Weinstock J
Life Sci; 1986 Jun; 38(23):2087-96. PubMed ID: 2872567
[TBL] [Abstract][Full Text] [Related]
3. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
Srivastava LK; Ross GM; Bajwa SB; Mishra RK
Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
[TBL] [Abstract][Full Text] [Related]
4. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
5. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
6. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
Cincotta M; de Vries DJ; Beart PM
Neurosci Lett; 1985 Oct; 61(1-2):85-9. PubMed ID: 2867505
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
Billard W; Ruperto V; Crosby G; Iorio LC; Barnett A
Life Sci; 1984 Oct; 35(18):1885-93. PubMed ID: 6387355
[TBL] [Abstract][Full Text] [Related]
9. Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.
Schulz DW; Stanford EJ; Wyrick SW; Mailman RB
J Neurochem; 1985 Nov; 45(5):1601-11. PubMed ID: 2864398
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of binding of 3H-SCH-23390 to D-1 dopaminergic receptor sites in rat striatal tissue.
Faedda G; Kula NS; Baldessarini RJ
Biochem Pharmacol; 1989 Feb; 38(3):473-80. PubMed ID: 2563653
[TBL] [Abstract][Full Text] [Related]
11. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
Leff SE; Creese I
Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
[TBL] [Abstract][Full Text] [Related]
12. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
13. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
14. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
Hess EJ; Battaglia G; Norman AB; Iorio LC; Creese I
Eur J Pharmacol; 1986 Feb; 121(1):31-8. PubMed ID: 2869957
[TBL] [Abstract][Full Text] [Related]
15. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--III. The effects of lesions in the parafascicular-intralaminar nuclei on D2 dopamine receptors and high affinity dopamine uptake.
Kilpatrick IC; Jones MW; Pycock CJ; Riches I; Phillipson OT
Neuroscience; 1986 Nov; 19(3):991-1005. PubMed ID: 2948134
[TBL] [Abstract][Full Text] [Related]
16. D1 and D2 dopamine receptors in caudate-putamen of nonhuman primates (Macaca fascicularis).
Madras BK; Fahey MA; Canfield DR; Spealman RD
J Neurochem; 1988 Sep; 51(3):934-43. PubMed ID: 2970527
[TBL] [Abstract][Full Text] [Related]
17. Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors.
Sibley DR; Leff SE; Creese I
Life Sci; 1982 Aug; 31(7):637-45. PubMed ID: 6127585
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
19. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
O'Boyle KM; Waddington JL
Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
[TBL] [Abstract][Full Text] [Related]
20. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
Closse A; Frick W; Markstein R; Maurer R; Nordmann R
J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
